{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:56:14Z","timestamp":1781906174762,"version":"3.54.5"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Fecal microbiota transplantation (FMT) has gained increasing attention as a novel therapeutic approach for treating ulcerative colitis (UC), a chronic inflammatory bowel disease that causes an imbalance in the gut microbiota. Although FMT has demonstrated the potential to induce remission in UC patients, the most effective route of administration remains an area of active investigation. This narrative review provides a comprehensive comparison of different FMT delivery methods, such as oral capsules, enemas, colonoscopy, and nasogastric or nasoenteric tubes, across a range of clinically relevant parameters, including efficacy, safety, patient satisfaction, microbiota changes, pretreatment protocols, and cost-effectiveness. Furthermore, we examined how post-FMT dietary interventions may influence microbial engraftment and improve the long-term outcomes in patients with UC. In addition to assessing these practical and clinical factors, this review highlights the importance of patient-centered considerations, such as the tolerability and convenience of each administration route. The integration of these findings can provide valuable insights into how different FMT routes affect disease outcomes and guide clinicians in optimizing the treatment for individual patients. By synthesizing current evidence on these key variables, we aimed to identify the most effective and feasible FMT approach for UC. Establishing standardized protocols for FMT administration, informed by this analysis, will be crucial for ensuring consistency in clinical practice, improving patient outcomes, and minimizing adverse events. The insights from this review will help pave the way for more targeted and individualized FMT strategies, ultimately enhancing the therapeutic landscape of UC management.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003841","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T03:00:09Z","timestamp":1756782009000},"page":"6599-6611","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["A narrative review on fecal microbiota transplantation routes in ulcerative colitis: identifying the optimal approach across key parameters"],"prefix":"10.1097","volume":"87","author":[{"given":"Rohan","family":"Singhal","sequence":"first","affiliation":[{"name":"Department of Medicine, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Ghadvaje","sequence":"additional","affiliation":[{"name":"Faculty of General Medicine, Smolensk State Medical University, Smolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanditha","family":"Karra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Osmania Medical College, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Teja","family":"Gadde","sequence":"additional","affiliation":[{"name":"Department of Medicine, All India Institute of Medical Sciences (AIIMS), Mangalagiri, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Chandra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Deccan College of Medical Sciences, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat Krishna Teja","family":"Voruganti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Gandhi Medical College, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navya Pillikunte","family":"Doddareddy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Bangalore Medical College and Research Institute, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Iftikhar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Akhtar Saeed Medical and Dental College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirath","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Trinity Medical Sciences University School of Medicine, Saint Vincent and the Grenadines"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"R1-20260204","doi-asserted-by":"crossref","first-page":"2666\u201378","DOI":"10.3748\/wjg.v29.i17.2666","article-title":"Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: a randomized controlled trial","volume":"29","author":"Lahtinen","year":"2023","journal-title":"World J Gastroenterol"},{"key":"R3-20260204","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jcm9010094","article-title":"Ulcerative colitis: current and emerging treatment strategies","volume":"9","author":"Kayal","year":"2019","journal-title":"J Clin Med"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"otaa067","DOI":"10.1093\/crocol\/otaa067","article-title":"Fecal microbiota transplantation for ulcerative colitis: an evolving therapy","volume":"2","author":"Sood","year":"2020","journal-title":"Crohns Colitis 360"},{"key":"R5-20260204","doi-asserted-by":"crossref","first-page":"100026","DOI":"10.1016\/j.medmic.2020.100026","article-title":"Long term management of ulcerative colitis with faecal microbiota transplantation","volume":"6","author":"Singh","year":"2020","journal-title":"Med Microecol"},{"key":"R6-20260204","first-page":"3204\u201312","article-title":"Current treatment of ulcerative colitis","volume":"17","author":"Meier","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R8-20260204","doi-asserted-by":"crossref","first-page":"229\u201339","DOI":"10.1177\/1756283X15607414","article-title":"Fecal microbiota transplantation: in perspective","volume":"9","author":"Gupta","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"R9-20260204","first-page":"224\u201328","article-title":"Fecal transplantation indications in ulcerative colitis","volume":"89","author":"Laszlo","year":"2016","journal-title":"Clujul Med"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"28\u201342","DOI":"10.5056\/jnm21221","article-title":"Gut microbiota and therapy research group under the Korean society of neurogastroenterology and motility. clinical practice guidelines for fecal microbiota transplantation in Korea","volume":"28","author":"Gweon","year":"2022","journal-title":"J Neurogastroenterol Motil"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"369\u201378","DOI":"10.1093\/ecco-jcc\/jjab165","article-title":"Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the CRAFT UC randomised controlled trial","volume":"16","author":"Sarbagili Shabat","year":"2022","journal-title":"J Crohns Colitis"},{"key":"R12-20260204","doi-asserted-by":"crossref","first-page":"156\u201364","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"Jama"},{"key":"R13-20260204","first-page":"141\u201351","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R14-20260204","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterol"},{"key":"R15-20260204","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterol"},{"key":"R16-20260204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","article-title":"Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study","volume":"21","author":"Crothers","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"R17-20260204","doi-asserted-by":"crossref","first-page":"e0133925","DOI":"10.1371\/journal.pone.0133925","article-title":"Low-level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis","volume":"10","author":"Damman","year":"2015","journal-title":"PLoS One"},{"key":"R18-20260204","doi-asserted-by":"crossref","first-page":"2155\u201365","DOI":"10.1097\/MIB.0b013e31829ea325","article-title":"Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis","volume":"19","author":"Kump","year":"2013","journal-title":"Inflam Bowel Dis"},{"key":"R19-20260204","doi-asserted-by":"crossref","first-page":"975\u201380","DOI":"10.5009\/gnl15456","article-title":"Coordinated hospital-home fecal microbiota transplantation via percutaneous endoscopic cecostomy for recurrent steroid-dependent ulcerative colitis","volume":"10","author":"Ni","year":"2016","journal-title":"Gut Liver"},{"key":"R20-20260204","doi-asserted-by":"crossref","first-page":"621\u201328","DOI":"10.1111\/1751-2980.12938","article-title":"Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis","volume":"21","author":"Chen","year":"2020","journal-title":"J Dig Dis"},{"key":"R21-20260204","doi-asserted-by":"crossref","first-page":"6612970","DOI":"10.1155\/2021\/6612970","article-title":"Fecal microbiota transplantation as therapy for the treatment of active ulcerative colitis: a systematic review and meta-analysis","volume":"2021","author":"Liu","year":"2021","journal-title":"Gastroenterol Res Pract"},{"key":"R22-20260204","doi-asserted-by":"crossref","first-page":"802","DOI":"10.21037\/atm-22-3236","article-title":"Efficacy and safety of fecal microbiota transplantation for the induction of remission in active ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Wei","year":"2022","journal-title":"Ann Transl Med"},{"key":"R23-20260204","doi-asserted-by":"crossref","first-page":"534\u201348","DOI":"10.1111\/1751-2980.12933","article-title":"Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: a systematic review and meta-analysis","volume":"21","author":"Zhao","year":"2020","journal-title":"J Dig Dis"},{"key":"R24-20260204","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1038\/s41598-023-41182-6","article-title":"Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis","volume":"13","author":"Feng","year":"2023","journal-title":"Sci Rep"},{"key":"R25-20260204","doi-asserted-by":"crossref","first-page":"213\u201324","DOI":"10.1111\/apt.14173","article-title":"Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis","volume":"46","author":"Costello","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-20260204","doi-asserted-by":"crossref","first-page":"808\u201317","DOI":"10.1093\/ibd\/izac135","article-title":"Efficacy of fecal microbiota transplantation in the treatment of active ulcerative colitis: a systematic review and meta-analysis of double-blind randomized controlled trials","volume":"29","author":"El Hage Chehade","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"R27-20260204","doi-asserted-by":"crossref","first-page":"e3765","DOI":"10.1097\/MD.0000000000003765","article-title":"Fecal microbiota transplantation as a novel therapy for ulcerative colitis: a systematic review and meta-analysis","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R28-20260204","first-page":"CD012774","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","volume":"11","author":"Imdad","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R29-20260204","doi-asserted-by":"crossref","first-page":"869\u201380","DOI":"10.1007\/s40264-019-00809-2","article-title":"Long-term safety and efficacy of fecal microbiota transplant in active ulcerative colitis","volume":"42","author":"Ding","year":"2019","journal-title":"Drug Saf"},{"key":"R30-20260204","doi-asserted-by":"crossref","first-page":"1025\u201334","DOI":"10.1007\/s00384-020-03599-7","article-title":"Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis","volume":"35","author":"Tang","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"R31-20260204","doi-asserted-by":"crossref","first-page":"1702\u201309","DOI":"10.1097\/MIB.0000000000001228","article-title":"Systematic review and meta-analysis: fecal microbiota transplantation for the treatment of active ulcerative colitis","volume":"23","author":"Narula","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R32-20260204","doi-asserted-by":"crossref","first-page":"5480961","DOI":"10.1155\/2018\/5480961","article-title":"The Value of fecal microbiota transplantation in the treatment of ulcerative colitis patients: a systematic review and meta-analysis","volume":"2018","author":"Cao","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"R33-20260204","doi-asserted-by":"crossref","first-page":"1452\u201359","DOI":"10.1038\/ajg.2012.93","article-title":"The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?","volume":"107","author":"Damman","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R34-20260204","doi-asserted-by":"crossref","first-page":"73\u201381","DOI":"10.1159\/000007798","article-title":"Potential uses of intravenous proton pump inhibitors to control gastric acid secretion","volume":"62","author":"Metz","year":"2000","journal-title":"Digestion"},{"key":"R35-20260204","doi-asserted-by":"crossref","first-page":"S841","DOI":"10.1093\/ofid\/ofz360.2112","article-title":"Proton pump inhibitor use on efficacy of fecal microbiota transplant administered by trans-oral routes for Clostridioides difficile infection: a systematic review and analysis","volume":"6","author":"Hong","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R36-20260204","doi-asserted-by":"crossref","first-page":"597\u2013601","DOI":"10.1097\/MPG.0b013e318292fa0d","article-title":"Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis","volume":"56","author":"Kunde","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R37-20260204","doi-asserted-by":"crossref","first-page":"1180\u201399","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R38-20260204","doi-asserted-by":"crossref","first-page":"51\u201358","DOI":"10.1111\/jgh.12727","article-title":"Fecal microbiota transplantation through mid-gut for refractory Crohn\u2019s disease: safety, feasibility, and efficacy trial results","volume":"30","author":"Cui","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R39-20260204","doi-asserted-by":"crossref","first-page":"1620\u201330","DOI":"10.1038\/ajg.2013.257","article-title":"Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation","volume":"108","author":"Angelberger","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R40-20260204","doi-asserted-by":"crossref","first-page":"5\u201314","DOI":"10.3748\/wjg.v24.i1.5","article-title":"Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation","volume":"24","author":"Shen","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R41-20260204","doi-asserted-by":"crossref","first-page":"e0157259","DOI":"10.1371\/journal.pone.0157259","article-title":"Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis","volume":"11","author":"Shi","year":"2016","journal-title":"PloS One"},{"key":"R42-20260204","doi-asserted-by":"crossref","first-page":"3786\u201396","DOI":"10.12998\/wjcc.v8.i17.3786","article-title":"Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients","volume":"8","author":"Zhong","year":"2020","journal-title":"World J Clin Cases"},{"key":"R43-20260204","doi-asserted-by":"crossref","first-page":"676\u201384","DOI":"10.1002\/ibd.21775","article-title":"Fecal bacteriotherapy for ulcerative colitis: patients are ready; are we?","volume":"18","author":"Kahn","year":"2012","journal-title":"Inflam Bowel Dis"},{"key":"R44-20260204","doi-asserted-by":"crossref","first-page":"1506\u201313","DOI":"10.1097\/MIB.0b013e318281f520","article-title":"Patient perceptions of fecal microbiota transplantation for ulcerative colitis","volume":"19","author":"Kahn","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R45-20260204","doi-asserted-by":"crossref","first-page":"322\u201330","DOI":"10.1097\/MEG.0000000000000783","article-title":"Patients\u2019 views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?","volume":"29","author":"Zeitz","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R46-20260204","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.21037\/atm-21-3683","article-title":"Patients and physicians\u2019 attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Trans Med"},{"key":"R47-20260204","doi-asserted-by":"crossref","first-page":"517597","DOI":"10.1155\/2015\/517597","article-title":"Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease","volume":"2015","author":"Wei","year":"2015","journal-title":"Gastroenterol Res Pract"},{"key":"R48-20260204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12910-017-0200-2","article-title":"How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study","volume":"18","author":"Ma","year":"2017","journal-title":"BMC Med Ethics"},{"key":"R49-20260204","doi-asserted-by":"crossref","first-page":"10907\u201314","DOI":"10.3748\/wjg.v21.i38.10907","article-title":"Gastroenterologist perceptions of faecal microbiota transplantation","volume":"21","author":"Paramsothy","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R50-20260204","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.1055\/s-0042-105205","article-title":"Colonic transendoscopic enteral tubing: a novel way of transplanting fecal microbiota","volume":"4","author":"Peng","year":"2016","journal-title":"Endosc Int Open"},{"key":"R51-20260204","first-page":"30","article-title":"Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness","volume":"32","author":"Ramai","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"R52-20260204","doi-asserted-by":"crossref","first-page":"A524","DOI":"10.1289\/ehp.116-a524","article-title":"The yuck factor: when disgust meets discovery","volume":"116","author":"Schmidt","year":"2008","journal-title":"Environ Health Perspect"},{"key":"R53-20260204","first-page":"1506","article-title":"Ethical issues in fecal microbiota transplantation in practice","volume":"19","author":"Ma","journal-title":"Inflamm Bowel Dis"},{"key":"R54-20260204","doi-asserted-by":"crossref","first-page":"1359\u201371","DOI":"10.1177\/1049732314568199","article-title":"Media discourse on the social acceptability of fecal transplants","volume":"25","author":"Chuong","year":"2015","journal-title":"Qual Health Res"},{"key":"R55-20260204","first-page":"e120","article-title":"Fecal microbiota transplantation for the treatment of ulcerative colitis: a qualitative assessment of patient perceptions and experiences","volume":"4","author":"Chauhan","year":"2021","journal-title":"J Can Asso Gastroenterol"},{"key":"R56-20260204","doi-asserted-by":"crossref","first-page":"752\u201361","DOI":"10.1016\/j.jval.2017.02.005","article-title":"Ulcerative colitis treatment patterns and cost of care","volume":"20","author":"Null","year":"2017","journal-title":"Value Health"},{"key":"R57-20260204","doi-asserted-by":"crossref","first-page":"357\u201362","DOI":"10.1155\/2015\/627370","article-title":"Ulcerative colitis-associated hospitalization costs: a population-based study","volume":"29","author":"Coward","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R58-20260204","doi-asserted-by":"crossref","first-page":"889\u201397","DOI":"10.1016\/j.cgh.2019.07.022","article-title":"Lifetime economic burden of Crohn\u2019s disease and ulcerative colitis by age at diagnosis","volume":"18","author":"Lichtenstein","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R59-20260204","doi-asserted-by":"crossref","first-page":"70\u201378","DOI":"10.1111\/jgh.16015","article-title":"Fecal microbiota transplantation for patients with active ulcerative colitis: a cost-effectiveness analysis","volume":"38","author":"Yao","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"key":"R60-20260204","first-page":"88894\u2013903","article-title":"Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"R61-20260204","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12879-015-0930-z","article-title":"Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent clostridium difficile infection","volume":"15","author":"Hirsch","year":"2015","journal-title":"BMC Infect Dis"},{"key":"R62-20260204","doi-asserted-by":"crossref","first-page":"420\u201331","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet"},{"key":"R63-20260204","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.14309\/00000434-201310001-00575","article-title":"comparative cost analysis of fecal microbiota transplant and antibiotic treatment for recurrent clostridium difficile infection: 575","volume":"108","author":"Kelly","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R64-20260204","doi-asserted-by":"crossref","first-page":"1229148","DOI":"10.3389\/fmed.2023.1229148","article-title":"Fecal microbiota transplantation for treatment of refractory or recurrent clostridioides difficile infection in Taiwan: a cost-effectiveness analysis","volume":"10","author":"Lan","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R65-20260204","doi-asserted-by":"crossref","first-page":"1515\u201323","DOI":"10.1111\/jgh.15002","article-title":"Cost-effectiveness analysis of fecal microbiota transplantation for recurrent clostridium difficile infection in patients with inflammatory bowel disease","volume":"35","author":"You","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"R66-20260204","doi-asserted-by":"crossref","first-page":"1411898","DOI":"10.3389\/fgstr.2024.1411898","article-title":"Awareness and acceptability of gut microbiome transfer","volume":"3","author":"Tweedie-Cullen","year":"2024","journal-title":"Front Gastroenterol"},{"key":"R67-20260204","doi-asserted-by":"crossref","first-page":"88\u201388","DOI":"10.21037\/amj.2017.06.12","article-title":"Cross cultural perspectives on ethics and regulation of fecal microbiota for transplantation","volume":"2","author":"Qiu","year":"2017","journal-title":"AME Med J"},{"key":"R68-20260204","first-page":"34\u201345","article-title":"(2017). Ethical issues in fecal microbiota transplantation in practice","volume":"17","author":"Ma","year":"2017","journal-title":"Am J Bio"},{"key":"R69-20260204","article-title":"Ethical implications of recruiting universal stool donors for faecal microbiota transplantation","author":"Mikail","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R70-20260204","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1755-8794-4-72","article-title":"\u201cWho owns your poop?\u201d: insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies","volume":"4","author":"Hawkins","year":"2011","journal-title":"BMC Med Genomics"},{"key":"R71-20260204","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1002\/imt2.62","article-title":"Donors\u2019 experiences and attitudes of fecal microbiota transplantation: an empirical bioethics study from China","volume":"1","author":"Ma","year":"2022","journal-title":"Imeta"},{"key":"R74-20260204","doi-asserted-by":"crossref","first-page":"e0215921","DOI":"10.1128\/spectrum.02159-21","article-title":"A matching strategy to guide donor selection for ulcerative colitis in fecal microbiota transplantation: meta-analysis and analytic hierarchy process","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol Spectr"},{"key":"R75-20260204","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcimb.2019.00002","article-title":"The super-donor phenomenon in fecal microbiota transplantation","volume":"9","author":"Wilson","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"R76-20260204","first-page":"2402\u201314","article-title":"Gut microbial metabolome in inflammatory bowel disease: from association to therapeutic perspectives","volume":"20","author":"Li","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"R77-20260204","first-page":"5","article-title":"Dietary management for faecal microbiota transplant: an international survey of clinical and research practice, knowledge and attitudes","volume":"24","author":"Clancy","journal-title":"World J Gastroenterol"},{"key":"R78-20260204","doi-asserted-by":"crossref","first-page":"1128\u201339","DOI":"10.1038\/s12276-020-0469-y","article-title":"Fecal microbial transplantation and a high fiber diet attenuates emphysema development by suppressing inflammation and apoptosis","volume":"52","author":"Jang","year":"2020","journal-title":"Exp Mol Med"},{"key":"R79-20260204","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.3390\/molecules26226802","article-title":"Soluble dietary fiber, one of the most important nutrients for the gut microbiota","volume":"26","author":"Guan","year":"2021","journal-title":"Molecules"},{"key":"R80-20260204","doi-asserted-by":"crossref","first-page":"e00224","DOI":"10.14309\/ctg.0000000000000224","article-title":"Fecal microbiota transplantation for ulcerative colitis: the optimum timing and gut microbiota as predictors for long-term clinical outcomes","volume":"11","author":"Li","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"R81-20260204","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3390\/nu14132559","article-title":"Effects of dietary fibers on short-chain fatty acids and gut microbiota composition in healthy adults: a systematic review","volume":"14","author":"Vinelli","year":"2022","journal-title":"Nutrients"},{"key":"R82-20260204","first-page":"597","article-title":"Probiotics, prebiotics, and postbiotics in health and disease","volume":"56","author":"Ji","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R83-20260204","doi-asserted-by":"crossref","first-page":"6715\u201332","DOI":"10.3748\/wjg.v27.i39.6715","article-title":"Microbiota shaping \u2013 the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: a systematic review","volume":"27","author":"Baldi","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R84-20260204","doi-asserted-by":"crossref","first-page":"1\u201324","DOI":"10.1155\/2022\/5121496","article-title":"Fecal microbiota transplantation combined with a low fodmap diet for the treatment of irritable bowel syndrome with predominant diarrhea","volume":"2022","author":"Huang","year":"2022","journal-title":"Oxidative Med Cell Longev"},{"key":"R85-20260204","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.56579","article-title":"A review of the efficacy of the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet in managing gastrointestinal symptoms related to cancer treatment","author":"Almasaudi","year":"2024","journal-title":"Cureus"},{"key":"R86-20260204","doi-asserted-by":"crossref","first-page":"2401\u201313","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial","volume":"71","author":"Kedia","year":"2022","journal-title":"Gut"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:04:23Z","timestamp":1770217463000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":82,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003841","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"2024-11-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}